UK MPs urge ministers to curb Palantir role in public data systems

Traders Union
All News
Financial News
UK MPs on Palantir in public data

Highlights

UK House of Commons technology committee urges ministers to trigger a 2027 break clause in Palantir's £330 million NHS Federated Data Platform contract over data security and vendor lock-in concerns.
MPs highlight the risk of an overreliance on U.S.-based Palantir for critical NHS and Ministry of Defence analytics contracts—including a £240 million MoD deal awarded without competitive tender—warning this creates public sector vulnerabilities.
Political backlash intensifies as London mayor blocks a £50 million Metropolitan Police contract with Palantir amid procurement concerns, while the government affirms digital platforms' role in improving public services but acknowledges supplier concentration risks.

Committee report targets NHS contract and supplier dependence

As reported by the Financial Times, the House of Commons technology committee says Palantir should not hold such a significant role across sensitive UK public sector data systems and urges ministers to activate a 2027 break clause in the company's £330 million contract for the NHS Federated Data Platform.

The FDP is designed to connect separate NHS datasets into a single system, but MPs warn that Palantir's expanding presence creates an unacceptable point of weakness and increases the risk of vendor lock-in. The committee says reliance on a small number of U.S.-based providers could leave efforts to modernize public services vulnerable to foreign actors and adds that dependence on overseas digital suppliers is a weakness that adversaries can exploit.

The MPs also call on the government to clarify the exact nature of Palantir's access to NHS patient data after reports that NHS England granted external staff from companies including Palantir unlimited access to patient data while working on part of the platform. They further ask ministers to explain why Palantir secured a £240 million Ministry of Defence contract for data analytics capabilities over three years without a competitive tender process.

Political backlash and wider public sector implications

Palantir rejects the criticism, with UK head Louis Mosley accusing the committee of putting politics ahead of public services and ignoring evidence that the company's technology improves NHS operations, crime outcomes and military capability. He says the MPs are pursuing headlines at the expense of patient care.

The dispute reflects wider scrutiny of Palantir's UK public sector footprint, which includes contracts with the Ministry of Defence, police forces and the Financial Conduct Authority. Its NHS role has become particularly contentious, with some staff boycotting the platform on ethical grounds even as supporters argue the technology helps improve patient outcomes.

Pressure on the company has also extended beyond the health service. Last month, London mayor Sir Sadiq Khan's office intervened to stop the Metropolitan Police from awarding Palantir a £50 million contract after concerns about the procurement process and value for money.

The committee says its conclusions are not driven by ideology or doubts about the quality of Palantir's products, but argues the government is too comfortable with concentration among a small group of digital suppliers and lacks a clear plan for building a modern digital state. A government spokesperson says digital platforms are already improving public services, adds that the NHS Federated Data Platform is helping join up care and speed cancer diagnoses, and says ministers are working to reduce reliance on any single tech supplier while considering the committee's recommendations.

In our earlier article on Palantir (PLTR) price analysis, we reviewed how the stock was holding above its short- and medium-term moving averages after stronger-than-expected Q1 2026 results, supported by rising adoption of its AI platforms and fresh government contract wins. We also noted that mixed momentum indicators and overbought signals were increasing the risk of near-term volatility, even as the broader narrative remained tied to continued public-sector deal flow.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.